November 18, 2020 NIAID Funding News Read this full edition online at https://www.niaid.nih.gov/grants-contracts/funding-news Feature Articles Intelligence, creativity, and dedication are highly valued attributes among investigators. Less celebrated, but equally critical to a successful career in biomedical research, is good grantsmanship. We interviewed Dr. John J. McGowan, NIAID's longtime deputy director for science management, about NIAID's efforts to empower applicants by providing online resources. Opportunities and Resources NIAID intends to fund collaborative, multidisciplinary program project awards to discover, design, and develop pan-coronavirus vaccine candidates capable of providing broad protective immunity to multiple coronavirus strains. Simple, inexpensive, rapid self-testing assays to directly detect HIV could make it easier for people to monitor themselves for acute or early HIV infection and allow people to monitor their viral suppression status during therapy. Through a new initiative, NIAID seeks applications proposing research developing and evaluating novel targeting technologies to deliver anti-HIV gene therapies to specific cells in vivo. In The News NIAID is operating under a continuing resolution through December 11, 2020. Still, we've posted initial paylines, a financial management plan, and more for fiscal year (FY) 2021. NIAID grantees may charge personal protective equipment (PPE) as a direct cost when the PPE will be used to directly assist in safely carrying out clinical activities and direct interactions with patients participating in clinical trials and clinical research studies. Applicants, offerors, grantees, and contractors may request exceptions to the single institutional review board (sIRB) policy for multi-site human subjects research if the pandemic has temporarily made such an arrangement impractical. Although the live events of the 2020 NIH Virtual Seminar on Program Funding and Grants Administration have concluded, you can still take advantage of the resources NIH provided. Institutions must maintain an up-to-date written, enforced Financial Conflict of Interest (FCOI) policy and post the policy on their publicly accessible website. Advice Corner Your Final Research Performance Progress Report should cover the entire period of performance, summarizing progress made toward the achievement of the originally stated aims, identifying of significant results, and listing relevant publications. Reader Questions New Funding Opportunities - NOT-OD-21-020, Notice of Special Interest: Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp, Clinical Trial Optional)
- PA-21-071, Research Supplements to Promote Diversity in Health-Related Research (Admin Supp, Clinical Trial Not Allowed)
- PAR-21-070, Detection of HIV for Self-Testing (R61/R33, Clinical Trial Not Allowed)
- NOT-AI-21-002, Emergency Awards—Notice of Special Interest (NOSI) on Pan-Coronavirus Vaccine Development Program Projects
- PAR-21-038, Stephen I. Katz Early Stage Investigator Research Project Grant (R01, Clinical Trial Not Allowed)
- PAR-20-315, Limited Competition—Lasker Clinical Research Scholars Transition Award (R00, Clinical Trial Optional)
Find other announcements at NIAID Opportunities & Announcements. Send suggestions or comments to deaweb@niaid.nih.gov. |
No comments:
Post a Comment